Professional Summary
Professional Overview
Travis Wager is the Co-Founder, President and Chief Scientific Officer (CSO) of Rgenta Therapeutics Inc., a Boston-based biopharmaceutical company focused on developing innovative therapies for neurological and neurodegenerative diseases. With over 15 years of industry experience, he brings a strong background in medicinal chemistry, drug discovery, and pharmaceutical research and development.
Experience Summary
Current Role
As the Co-Founder, President and CSO of Rgenta Therapeutics, Mr. Wager is responsible for driving the company's scientific strategy and overseeing all research and development activities. He has played a pivotal role in establishing the company's technology platform, building a diverse pipeline of drug candidates, and fostering strategic partnerships to accelerate the translation of promising therapeutic approaches.
Career Progression
Prior to co-founding Rgenta, Mr. Wager held various leadership roles at Pfizer, where he served as a member of the Discovery Network Leadership Team, an External Opportunities Scout for Neuroscience, and the Cardiovascular and Metabolic Disease (CVMED) Design Head. He also held the position of Chemistry Point of Contact in Pfizer's Neuroscience Department, where he demonstrated his expertise in medicinal chemistry and drug discovery. Before joining Pfizer, Mr. Wager was a Vice President of Research at Aquinnah Pharmaceuticals, where he contributed to the advancement of novel therapeutic approaches for neurodegenerative diseases.
Academic Background
Mr. Wager holds a Ph.D. in Organic Chemistry from the Massachusetts Institute of Technology (MIT), where he conducted groundbreaking research in the field of medicinal chemistry. His academic achievements have been recognized through numerous publications in peer-reviewed journals and presentations at industry conferences.
Areas of Expertise
- Medicinal chemistry and drug discovery
- Neuroscience and neurodegenerative disease research
- Pharmaceutical research and development
- Strategic leadership and scientific vision
- Fostering collaborative partnerships and driving innovation
Professional Impact
Throughout his career, Mr. Wager has played a pivotal role in advancing the understanding and treatment of neurological and neurodegenerative disorders. His contributions have been instrumental in the development of several drug candidates, some of which have progressed to clinical trials. At Rgenta Therapeutics, he is leading the charge in the company's mission to revolutionize the treatment of these debilitating conditions and improve the lives of patients worldwide.
Conclusion
With his extensive experience, exceptional scientific expertise, and proven track record of successful drug discovery and development, Travis Wager is poised to drive Rgenta Therapeutics' mission forward and make a lasting impact on the field of neuroscience.
